Dr Reddys profit rises marginally to Rs 1,410 cr in Jun qtr
The Hyderabad-based drug major posted a net profit of Rs 1,392 crore in the year-ago period.
Consolidated revenue rose 11 per cent to Rs 8,545 crore in the period under review from Rs 7,673 crore a year earlier.
'We delivered double-digit growth this quarter over the same period last year, reflecting our strength in branded markets and positive momentum in the Nicotine Replacement Therapy portfolio," Dr Reddy's Co-Chairman & MD G V Prasad said.
The pricing pressure on Lenalidomide is expected to intensify in the US generics market, he noted.
'We remain focused on strengthening our base business by delivery of our pipeline assets, improving overall productivity and business development," Prasad said.
The company noted that growth during the quarter was broad-based, aided by contributions from the acquired consumer healthcare portfolio in nicotine replacement therapy (NRT) and sustained performance in the company's branded markets.
In the North American market, its revenue declined by 11 per cent year-on-year to Rs 3,412 crore in the June quarter as compared with Rs 3,846 crore in the year-ago period.
The decline was primarily due to increased price erosion in certain key products, including Lenalidomide, it stated.
In Europe, the company reported a revenue of Rs 1,274 crore for the first quarter as compared with Rs 526 crore in the year-ago period.
The growth in Europe was largely driven by revenues from the acquired NRT portfolio and incremental contributions from new product launches, though partly offset by price erosion, it stated.
In India, revenue stood at Rs 1,471 crore against Rs 1,325 crore, a growth of 11 per cent year-on-year.
Growth for the quarter was driven by introduction of new products, price increases and commercial execution, Dr Reddy's said.
Shares of the company ended 0.58 per cent up at Rs 1,247.55 apiece on the BSE. PTI MSS MSS SHW
view comments
First Published:
July 23, 2025, 18:15 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
11 minutes ago
- Time of India
Insurer rejects mediclaim citing 'mismatch' over Google Timeline; consumer forum gives man relief
Valsad: A Gujarat resident was shocked when an insurance company rejected his mediclaim on the grounds that his Google Timeline did not match the location of the hospital that had treated him. The man from Silvassa had to knock on the door of the Consumer Dispute Redressal Forum in Valsad district, which ruled in his favour and directed the company to settle the claim with interest. In its order of July 14, made available recently, the president of the consumer forum, B G Dave, directed the firm to pay Rs 48,251 (mediclaim amount) with 8 per cent interest within 30 days of the order. Vallabh Matka, who had a mediclaim policy from Go Digit General Insurance Limited, was admitted to a private hospital in Silvassa in September 2024 for four days after he contracted viral pneumonia. After his discharge, Matka submitted medical bills to the insurance company for reimbursement. However, it rejected the claim, saying there were discrepancies over his Google Timeline. Google Timeline, earlier called Location History, creates a map of the places a person has been and the routes the individual has taken on each of their devices. Left with no option, Matka approached the consumer forum, a quasi-judicial body with the power to make decisions and resolve certain disputes like a court. After being issued a notice, the company told the forum that there were many inconsistencies concerning Matka's claim. "Upon internal verification of the claim, we noted that there are multiple discrepancies in submitted bills, indoor case papers and we have also noted discrepancies from insured statement to his verified Google Timeline," the company told the forum. As per the customer's statement, his phone was with him during hospitalisation, but as per Google Timeline, "the hospital location was not found in the patient's Google Map", it said. The forum, however, relied on the hospital's statement and other records. "In the report by the insurance company, it has said that the patient was admitted to the hospital and received treatment but it seems that they wanted to reject the claim and are giving false reason that the Google map timeline is not matching," the forum said, ordering the firm to settle the claim and pay 8 per cent interest. PTI
Time of India
35 minutes ago
- Time of India
KRT IPO: Sattva-Blackstone backed REIT gets Sebi nod for Rs 4,800 crore raise; public issue likely to hit markets early August
Knowledge Realty Trust (KRT), a REIT sponsored by Sattva Group and Blackstone, has received approval from the Securities and Exchange Board of India (Sebi) to go ahead with its Rs 4,800-crore initial public offering . The public issue is expected to hit the market in the first week of August, according to PTI citing sources. Ahead of the IPO, KRT has already mobilised Rs 1,400 crore from institutional investors. The company had filed its draft red herring prospectus (DRHP) in March this year, as part of its plan to monetise 30 premium office assets spread across key Indian cities, ANI reported. The REIT owns over 46 million sq ft of rent-yielding office properties across 29 locations in Mumbai, Bengaluru and Hyderabad. Notable assets include One BKC and One World Center in Mumbai, Knowledge City and Knowledge Park in Hyderabad, and Cessna Business Park and Sattva Softzone in Bengaluru. Sources said the roadshow will begin this week, and the price band announcement is expected by August 30. Post listing, KRT is poised to become India's largest REIT by gross asset value, pegged at around Rs 62,000 crore. Its net operating income stood at Rs 3,432 crore in FY24. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Do You Speak English? You May Be Able To Work a USA Job From Home in Bangladesh US Jobs | Search ads Undo Following the IPO, sponsors Sattva Group and Blackstone will retain around 80% ownership in the trust. While Sattva declined to comment, sources said the trust will continue to adopt a brand-neutral approach, focusing on inorganic growth through third-party acquisitions. There are currently four REITs listed in India — Brookfield India Real Estate Trust, Embassy Office Parks REIT, Mindspace Business Parks REIT, and Nexus Select Trust. Except for Nexus, which is focused on retail spaces, the others are anchored in office real estate. Together, these four REITs manage over 126 million sq ft of Grade A office and retail space and have distributed over Rs 21,000 crore to unitholders since inception. Sattva Developers, headquartered in Bengaluru, has completed over 74 million sq ft of projects across seven cities, spanning commercial, residential, co-living, co-working, hospitality, and data centres. Another 75 million sq ft is currently in various stages of development. Global investment firm Blackstone continues to hold a substantial portfolio in India's commercial real estate sector. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Economic Times
35 minutes ago
- Economic Times
Lenskart secures shareholder nod to raise Rs 2,150 crore via IPO
Shareholders of omnichannel eyewear brand Lenskart have approved its initial public offering (IPO) plans, according to regulatory filings sourced from the Registrar of Companies (RoC).At its annual general meeting on Saturday, Lenskart's shareholders cleared the proposal to raise Rs 2,150 crore ($250 million) through the IPO. The total issue size is likely to be as much as $1 billion, according to people aware of the matter. One of the sources said the company is set to file its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (Sebi) in the coming days. With this, Lenskart will join other large new-age firms like Groww, Meesho, PhysicsWallah, and Pine Labs that are filing IPO documents this year. In total, nearly 14 venture-backed new-age companies are aiming to raise over Rs 20,000 crore from the public markets in 2025. Filings also showed that Lenskart's shareholders, including SoftBank, Kedaara Capital, Abu Dhabi Investment Authority, Fidelity and Temasek, have approved a new employee stock option plan, Esop 2025, comprising 7.2 million shares. Data from Tracxn shows that about 19% of Lenskart's shares are currently earmarked for its Esop pool. ET had reported on July 10 that Lenskart plans to issue additional shares to founder and CEO Peyush Bansal through a structured payout, which may increase his holding by 1.5-2%. Bansal and his sister Neha Bansal, also a cofounder, together own 14-15% of the company. Lenskart, which won The ET Startup Awards 2024 in the Startup of the Year category, operates in India and other markets such as the Middle East, Southeast Asia, Australia, Japan and South Korea. In FY24, Lenskart's operating revenue grew 43% year-on-year to Rs 5,428 crore, while its net loss narrowed to Rs 10 crore from Rs 64 crore in FY23. In an October interview with ET, Peyush Bansal said the company is investing $200 million in a new manufacturing plant in southern India. Currently, Lenskart makes frames and lenses at its facility in Rajasthan. Lenskart's last round of funding in June 2024 valued the company at $5 billion. US-based Fidelity marked up the valuation of the omnichannel eyewear retailer by more than a fifth to $6.1 billion at the end of April. The company's omnichannel strategy, combining its website with more than 2,500 retail outlets, has been a major growth driver. While online sales have outpaced store sales growth in the past two to three years, Lenskart continues to expand its offline footprint also showed that Lenskart has appointed PaySense cofounder Sayali Karanjkar and IndMoney founder Ashish Kashyap as independent directors on its Bansal has been named chairman, managing director and CEO of Lenskart, while Neha Bansal has been appointed executive director. Cofounder Amit Chaudhary has been named an executive director on the board.
